Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Mukherjee, Sumana ^a   Roth, Mark J ^a   Dawsey, Sanford M ^a   Yan, Wusheng ^a   Rodriguez Canales, Jaime ^a   Erickson, Heidi S ^a   Hu, Nan ^a   Goldstein, Alisa M ^a   Taylor, Philip R ^a   Richardson, Annely M ^a   Tangrea, Michael A ^a   Chuaqui, Rodrigo F ^a   Emmert Buck, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; MESSENGER RNA; STROMELYSIN; STROMELYSIN 2; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVATION; ENZYME LOCALIZATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; UPREGULATION; ZYMOGRAPHY; ENZYMOLOGY; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 77957284259     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-91     Document Type: Article

References (25)

1. Parkin MD, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Blot WJ, McLaughlin JK, Fraumeni JF. Esophageal cancer. Cancer Epidemiology and Prevention 2006, 697-706. New York: Oxford University Press, Schottenfeld D, Fraumeni JF Jr, 3.
3. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Intl J cancer 2002, 102:271-274.
4. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer manual for staging of cancer. 2(199):57-59. Philadelphia: J.B. Lippincott, 4.
5. Guo HQ, Wei WQ, Lu N, Cao J, Li ZL, Wand NP, Wang GQ, Pan QJ, Qiao YL. [Liquid-based cytology for esophageal carcinoma screening]. Ai Zheng 2009, 28:1243-1247.
6. Xuan Z, Shuang-Hong Z, Kun-He Z, Bi-Ming L, Jiang C. Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-and telomerase in the early diagnosis of esophageal carcinoma. World J Gasteroenterol 2005, 11:6090-6095.
7. Pan Q-J, Roth MJ, Guo H-Q, Kochman ML, Wang GQ, Henry M, Wei WQ, Giffen CA, Lu N, Abnet CC, Hao CQ, Taylor PR, Qiao YL, Dawsey SM. Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid based cytology in asymptomatic adults in Linxian, China. Acta Cytol 2008, 52:14-23.
8. Li Y, Ma J, Guo Q, Duan F, Tang F, Zheng P, Zhao Z, Lu G. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Dis Esophagus 2009, 22(8):664-7. 10.1111/j.1442-2050.2008.00928.x, 19191857.
9. Shima I, Sasaguri Y, Kusukaa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behaviour of esophageal carcinoma. Cancer 1992, 70(12):2747-2753. 10.1002/1097-0142(19921215)70:12<2747::AID-CNCR2820701204>3.0.CO;2-5, 1451050.
10. Ishibashi Y, Matsumoto T, Niwa M, Suzuki Y, Omura N, Hanyu N, Nakada K, Yanaga K, Yamada K, Ohkawa K, Kawakami M, Urashima M. CD 147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 2004, 101:1994-2000. 10.1002/cncr.20593, 15372476.
11. Samantaray S, Sharma S, Chattopadhyaya TK. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004, 130:37-44. 10.1007/s00432-003-0500-4, 14569466.
12. Mathew R, Khanna R, Kumar R, Mathur M, Shukla NK, Ralhan R. Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev 2002, 26:222-228. 10.1016/S0361-090X(02)00035-1, 12269770.
13. Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, Chen KN. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005, 100:1835-43. 10.1111/j.1572-0241.2005.50018.x, 16086722.
14. Brown PD, Bloxidge RE, Anderson E, Howell A. Expression of activated gelatinase in human invasive breast cancer. Clin Exp Metastasis 1993, 11:183-189. 10.1007/BF00114976, 8444010.
15. Erickson HS, Albert PS, Gillespie JW, Wallis BS, Rodriguez-Canales J, Linehan WM, Gonzalez S, Velasco A, Chuaqui RF, Emmert-Buck MR. Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samples. Lab Invest 2007, 87:951-962. 10.1038/labinvest.3700659, 17643124.
16. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 2001, 4:E83-E90.
17. Komosinska-Vassev K, Olczyk P, Winsz-Szczotka K, Kuznik-Trochna K, Klimek K, Olczyk K. Age- and gender-dependent changes in connective tissue remodeling: physiologic differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level. Gerontology 2010, 1-9. March 9, Experimental section.
18. Egebald M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174. 10.1038/nrc745, 11990853.
19. Westermarck J, Kahari V. Regulation of matrix metalloproteinase expression in tumor progression. FASEB 1999, 13:781-792.
20. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproetinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004, 4:617-629. 10.1038/nri1418, 15286728.
21. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behaviour. Annu Rev Cell Dev Biol 2001, 17:463-516. 10.1146/annurev.cellbio.17.1.463, 2792593, 11687497.
22. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839. 10.1161/01.RES.0000070112.80711.3D, 12730128.
23. Gao ZL, Zhang C, Du GY, Lu ZJ. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology 2007, 54:1591-5.
24. Rundhaug JE. Matrix metalloproteinases, angiogenesis, and cancer. Clinical Cancer Research 2003, 9:551-554.
25. Fridman R. Metalloproteinases and cancer. Cancer Metastasis Rev 2006, 25:7-8.